ici 118551 and epidermal growth factor

ici 118551 has been researched along with epidermal growth factor in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Busch, M; Funsch, B; Gradl, G; Lohse, MJ; Pschorr, J; Scheel, AA	1
Cho, CH; Li, ZJ; Liu, X; Sung, JJ; Wu, WK; Yu, L; Zhang, ST	1

Other Studies

2 other study(ies) available for ici 118551 and epidermal growth factor

Article	Year
Receptor-ligand interactions studied with homogeneous fluorescence-based assays suitable for miniaturized screening. Journal of biomolecular screening, 2001, Volume: 6, Issue:1 Topics: Betacellulin; Cell Line; Drug Evaluation, Preclinical; Epidermal Growth Factor; ErbB Receptors; Fluorescence; Fluorescent Dyes; Growth Substances; Humans; Intercellular Signaling Peptides and Proteins; Ligands; Miniaturization; Optics and Photonics; Propanolamines; Propranolol; Receptors, Adrenergic, beta-2; Receptors, Cell Surface; Recombinant Proteins; Sensitivity and Specificity	2001
Epidermal growth factor-induced esophageal cancer cell proliferation requires transactivation of beta-adrenoceptors. The Journal of pharmacology and experimental therapeutics, 2008, Volume: 326, Issue:1 Topics: Adrenergic beta-Antagonists; Atenolol; Cell Proliferation; Epidermal Growth Factor; Esophageal Neoplasms; Humans; Male; Middle Aged; Propanolamines; Receptors, Adrenergic, beta; Transcriptional Activation; Tumor Cells, Cultured	2008

Article

Year

Receptor-ligand interactions studied with homogeneous fluorescence-based assays suitable for miniaturized screening.

Journal of biomolecular screening, 2001, Volume: 6, Issue:1

Topics: Betacellulin; Cell Line; Drug Evaluation, Preclinical; Epidermal Growth Factor; ErbB Receptors; Fluorescence; Fluorescent Dyes; Growth Substances; Humans; Intercellular Signaling Peptides and Proteins; Ligands; Miniaturization; Optics and Photonics; Propanolamines; Propranolol; Receptors, Adrenergic, beta-2; Receptors, Cell Surface; Recombinant Proteins; Sensitivity and Specificity

2001

Epidermal growth factor-induced esophageal cancer cell proliferation requires transactivation of beta-adrenoceptors.

The Journal of pharmacology and experimental therapeutics, 2008, Volume: 326, Issue:1

Topics: Adrenergic beta-Antagonists; Atenolol; Cell Proliferation; Epidermal Growth Factor; Esophageal Neoplasms; Humans; Male; Middle Aged; Propanolamines; Receptors, Adrenergic, beta; Transcriptional Activation; Tumor Cells, Cultured

2008